Meso Scale Discovery Launches Its New U-PLEX® Platform for Personalized Immunoassay Multiplexing

Share Article

Meso Scale Discovery, a division of Meso Scale Diagnostics, LLC. (MSD®), is pleased to announce the introduction of its new U-PLEX platform. U-PLEX simplifies multiplexing and allows researchers ultimate flexibility to create their own multiplexed assays in real time in their labs.

Meso Scale Diagnostics, LLC. (MSD)
U-PLEX combines MSD's industry-leading performance with the ability for our customers to build their own multiplex panels at the bench in an easy and cost-effective way

Meso Scale Discovery, a division of Meso Scale Diagnostics, LLC. (MSD®), is pleased to announce the introduction of its new U-PLEX platform. U-PLEX simplifies multiplexing and allows researchers ultimate flexibility to create their own multiplexed assays in real time in their labs.

The open U-PLEX platform is compatible with virtually any binding element including antibodies, proteins, peptides, carbohydrates, nucleic acids, and oligonucleotides. U-PLEX leverages MSD’s MULTI-ARRAY® technology, which has been widely adopted by researchers in pharmaceutical companies, universities, and clinical laboratories worldwide for its high sensitivity, excellent reproducibility, and wide dynamic range.

“The introduction of the U-PLEX platform is transformational for the multiplexing marketplace,” said Jacob Wohlstadter, President and Chief Executive Officer of MSD. “U-PLEX combines MSD's industry-leading performance with the ability for our customers to build their own multiplex panels at the bench in an easy and cost-effective way.”

MSD will immediately offer U-PLEX Development Packs that allow users to define their personal multiplex assays using their own antibodies or other binding reagents. In the upcoming months, MSD will offer a menu of U-PLEX single analyte assays that can be mixed and matched to create a customized panel. Preconfigured U-PLEX Kits with assays that have been optimized for multiplexing will also be available.

“Other methods for creating multiplex assays require very long and cumbersome protocols,” said Dr. James Wilbur, General Manager. “U-PLEX Development Packs provide the tools and reagents that condense this procedure into a simple, three-step process saving customers time and allowing them to focus on their important research.”

The U-PLEX platform adds to the ever-expanding list of MSD assays that includes the validated V-PLEX® assays for unsurpassed performance and quality and the S-PLEX™ assays with improved sensitivity and specificity. All of these assays are compatible with the SECTOR® S 600 and MESO® QuickPlex SQ 120 instruments.

For more information on the U-PLEX platform, call Customer Service at 1-240-314-2795; email customerservice(at)mesoscale(dot)com; or visit http://www.mesoscale.com/U-PLEX.

About Meso Scale Diagnostics, LLC.
Meso Scale Diagnostics, LLC., based in Rockville, Maryland, develops, manufactures, and markets instruments and assays for array-based biological measurements for research use in life sciences and for biodefense applications. MSD is the world’s leading provider of highly sensitive multiplex immunoassays. More information about MSD and its products can be found at http://www.mesoscale.com.

Contact
pr(at)mesoscale(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jonathan Klein-Evans
Visit website